Aletra Capital Partners

Aletra Capital Partners B.V. is a hands-on investment company with a dual focus. In Europe (Netherlands, Belgium, Germany), they target corporate divestitures of non-core business units, family-owned businesses facing succession issues, and stand-alone companies requiring turnaround management or growth acceleration. In Singapore, they focus on young ventures seeking bridge financing or (pre) Series A funding. The firm emphasizes close collaboration with management teams to enhance growth and value. They are willing to support activities such as restructuring or growth programs. A key characteristic is their use of their own funds, avoiding reliance on external investors or covenants. This allows them the flexibility to invest in opportunities they believe in and can add true value to. Aletra Capital Partners distinguishes itself through a long-term investment horizon, avoiding short-term “buy and flip” strategies that may be detrimental to the long-term health of the company. They seek companies with international potential through exports, alliances, international presence, or joint ventures, with understandable and scalable business models and open to new majority shareholders. Their investment focus in Europe encompasses medical technology and IT/software, including medical devices, assays, biomarkers and reagents, medical (embedded) IT, and general IT/software.

Medical technology, IT, software, medical devices, assays, biomarkers, reagents, medical (embedded) IT, general IT, software

Core thematic spaces, technologies, and target market segments of interest.